Anterior lamellar nanostructured artificial human cornea.
CAH/Ulc/2010
Phase 2 small_molecule completed
Quick answer
Anterior lamellar nanostructured artificial human cornea. for Severe Trophic Corneal Ulcers Refractory to Conventional Treatment is a Phase 2 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Severe Trophic Corneal Ulcers Refractory to Conventional Treatment
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed